Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease

Citation
Pn. Newsome et al., Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease, ALIM PHARM, 14(10), 2000, pp. 1295-1301
Citations number
44
Categorie Soggetti
Pharmacology,"da verificare
Journal title
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
ISSN journal
02692813 → ACNP
Volume
14
Issue
10
Year of publication
2000
Pages
1295 - 1301
Database
ISI
SICI code
0269-2813(200010)14:10<1295:LSRLAA>2.0.ZU;2-H
Abstract
Background: Retinol and other vitamin A derivatives affect the differentiat ion and growth of many tissues and have anti-tumour properties. Aim: To investigate serum retinol levels in patients with liver disease and hepatocellular carcinoma (HCC) and to assess its importance as a risk fact or for the development of HCC. Methods: Serum retinol levels were measured in healthy volunteers and 175 p atients (34 with chronic hepatitis C, 117 with cirrhosis, and 24 with HCC. Results: The serum retinol levels (mean +/- s.e.) in ng/mL, were 972.1 +/- 37.7 in the control group and 647 +/- 41.1 in patients with chronic hepatit is C. Serum retinol levels in patients with cirrhosis and HCC were lower th an in patients with cirrhosis alone (365.8 +/- 43.1 vs. 438.9 +/- 22.1, P < 0.04). In particular, there was a more significant difference in serum ret inol levels between Child-Pugh grade A patients with cirrhosis and Child-Pu gh grade A patients with cirrhosis/HCC (serum retinol levels 532.4 +/- 26.7 vs. 366.1 +/- 86.4, P < 0.03). There was a significant difference in serum retinol levels between normal controls and all patients' groups (P < 0.001 ). There were significantly lower serum retinol levels in cholestatic Child -Pugh grade A patients with cirrhosis compared with noncholestatic Child-Pu gh grade A patients with cirrhosis/HCC (411.5 +/- 30.3 vs. 579.7 +/- 32.7, P < 0.0004). Sixty percent of patients with Child-Pugh grade A cirrhosis/HC C had serum retinol levels below 350 ng/mL compared with only 18.4% of cirr hotics without HCC (chi (2)-test, P=0.01). No correlation was found between serum retinol levels and alpha FP or any other liver function tests, apart from serum albumin, which showed a positive correlation (r=0.61 P < 0.018) . Conclusions: There was a progressive reduction in serum retinol levels from controls to patients with liver cirrhosis. Those patients with cirrhosis a nd HCC had significantly lower values than patients with cirrhosis alone. S erum retinol levels may be a risk factor for the development of HCC.